These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17540541)

  • 1. Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia.
    Porton B; Wetsel WC
    Schizophr Res; 2007 Aug; 94(1-3):366-70. PubMed ID: 17540541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medial prefrontal cortical synapsin II knock-down induces behavioral abnormalities in the rat: examining synapsin II in the pathophysiology of schizophrenia.
    Dyck BA; Beyaert MG; Ferro MA; Mishra RK
    Schizophr Res; 2011 Aug; 130(1-3):250-9. PubMed ID: 21689907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.
    Tan ML; Dyck BA; Gabriele J; Daya RP; Thomas N; Sookram C; Basu D; Ferro MA; Chong VZ; Mishra RK
    Pharmacogenomics J; 2014 Feb; 14(1):63-9. PubMed ID: 23529008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the rat.
    Dyck BA; Tan ML; Daya RP; Basu D; Sookram CD; Thomas N; Mishra RK
    Schizophr Res; 2012 May; 137(1-3):32-8. PubMed ID: 22341900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.
    Weickert CS; Hyde TM; Lipska BK; Herman MM; Weinberger DR; Kleinman JE
    Mol Psychiatry; 2003 Jun; 8(6):592-610. PubMed ID: 12851636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
    Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
    Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
    Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
    Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA.
    Basu D; Tian Y; Hui P; Bhandari J; Johnson RL; Mishra RK
    Peptides; 2015 Apr; 66():58-62. PubMed ID: 25703303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies.
    Schmidt U; Buell DR; Ionescu IA; Gassen NC; Holsboer F; Cox MB; Novak B; Huber C; Hartmann J; Schmidt MV; Touma C; Rein T; Herrmann L
    Psychoneuroendocrinology; 2015 Feb; 52():43-58. PubMed ID: 25459892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotic drugs upregulate synapsin II in the prefrontal cortex of post-mortem samples obtained from patients with schizophrenia.
    Guest KA; Dyck BA; Shethwala S; Mishra RK
    Schizophr Res; 2010 Jul; 120(1-3):229-31. PubMed ID: 20434888
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Beneyto M; Meador-Woodruff JH
    Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B
    Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.
    Albert KA; Hemmings HC; Adamo AI; Potkin SG; Akbarian S; Sandman CA; Cotman CW; Bunney WE; Greengard P
    Arch Gen Psychiatry; 2002 Aug; 59(8):705-12. PubMed ID: 12150646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia.
    Beneyto M; Meador-Woodruff JH
    Synapse; 2006 Dec; 60(8):585-98. PubMed ID: 16983646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients.
    Gilabert-Juan J; Varea E; Guirado R; Blasco-Ibáñez JM; Crespo C; Nácher J
    Neurosci Lett; 2012 Nov; 530(1):97-102. PubMed ID: 23022470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
    Meador-Woodruff JH; Davis KL; Haroutunian V
    Neuropsychopharmacology; 2001 May; 24(5):545-52. PubMed ID: 11282254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia.
    Bunney WE; Bunney BG
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):138-46. PubMed ID: 10719142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls.
    Kozlovsky N; Scarr E; Dean B; Agam G
    Schizophr Res; 2006 Apr; 83(2-3):173-7. PubMed ID: 16460915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia.
    Stuart Gibbons A; Scarr E; McOmish CE; Hannan AJ; Thomas EA; Dean B
    Aust N Z J Psychiatry; 2008 Aug; 42(8):740-5. PubMed ID: 18622782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.
    Weickert CS; Ligons DL; Romanczyk T; Ungaro G; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
    Mol Psychiatry; 2005 Jul; 10(7):637-50. PubMed ID: 15940304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.